Indication
Viral infections
1 clinical trial
1 product
Clinical trial
Novel Antigens Targeted by ex Vivo Expanded T-Lymphocytes for Prevention or Treatment of Viral Infections Following Hematopoietic Stem Cell TransplantationStatus: Active (not recruiting), Estimated PCD: 2024-10-01
Product
Virus Specific T cells